Significance of Diabetic Kidney Disease Biomarkers in Predicting Metabolic-Associated Fatty Liver Disease

被引：3
作者：
Bae, Jaehyun [1 ]
Lee, Byung-Wan [2 ]
机构：
[1] Catholic Kwandong Univ, Int St Marys Hosp, Dept Internal Med, Div Endocrinol & Metab,Coll Med, Int St, Incheon 22711, South Korea
[2] Yonsei Univ, Dept Internal Med, Div Endocrinol & Metab, Coll Med, Seoul 03722, South Korea
来源：
BIOMEDICINES | 2023年 / 11卷 / 07期
关键词：
diabetic kidney disease; metabolic-associated fatty liver disease; biomarker; GELATINASE-ASSOCIATED LIPOCALIN; ACID-BINDING PROTEIN; SERUM CYSTATIN C; INSULIN-RESISTANCE; PROXIMAL TUBULE; THERAPEUTIC TARGETS; RENAL DYSFUNCTION; MOLECULE-1; KIM-1; URINARY ENZYMES; FETUIN-A;
D O I：
10.3390/biomedicines11071928
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Metabolic-associated fatty liver disease (MAFLD) and diabetic kidney disease (DKD) share various pathophysiological factors, and epidemiological evidence suggests that these two diseases are associated. Albuminuria and the estimated glomerular filtration rate, which are conventional biomarkers of DKD, are reportedly associated with the risk or severity of MAFLD. Recently, novel DKD biomarkers reflecting renal tubular injury have been introduced to complement conventional DKD markers. In this article, we looked at previous studies that showed an association between MAFLD and DKD, and also reviewed the significance of DKD biomarkers as predictive risk factors for MAFLD.
引用
收藏
页数：13
相关论文
共 50 条
  • [31] Diagnostic indicators and lifestyle interventions of metabolic-associated fatty liver disease
    Chen, Tianzhu
    Qin, Xiang
    Jiang, Jianping
    He, Beihui
    FRONTIERS IN NUTRITION, 2024, 11
  • [32] Development and validation of a nomogram for predicting metabolic-associated fatty liver disease in the Chinese physical examination population
    Zhou, Bingqian
    Gong, Ni
    Huang, Xinjuan
    Zhu, Jingchi
    Qin, Chunxiang
    He, Qingnan
    LIPIDS IN HEALTH AND DISEASE, 2023, 22 (01)
  • [33] A Bidirectional Association Between Obstructive Sleep Apnea and Metabolic-Associated Fatty Liver Disease
    Preshy, Anish
    Brown, James
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2023, 52 (03) : 509 - 520
  • [34] Comparison between metabolic-associated fatty liver disease and nonalcoholic fatty liver disease: From nomenclature to clinical outcomes
    Alomari, Mohammad
    Rashid, Mamoon Ur
    Chadalavada, Pravallika
    Ragheb, Jonathan
    Zafar, Hammad
    Suarez, Zoilo Karim
    Khazaaleh, Shrouq
    Gonzalez, Adalberto Jose
    Castro, Fernando J.
    WORLD JOURNAL OF HEPATOLOGY, 2023, 15 (04) : 477 - 496
  • [35] Gut Microbiota in Metabolic-associated Fatty Liver Disease and in Other Chronic Metabolic Diseases
    Hernandez-Ceballos, Winston
    Cordova-Gallardo, Jacqueline
    Mendez-Sanchez, Nahum
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2021, 9 (02) : 227 - 238
  • [36] Early Kidney Dysfunction in Metabolic-Associated Fatty Liver Disease: Is Transient Elastography Useful as a Screening Method?
    Freitas, Marta
    Macedo Silva, Vitor
    Xavier, Sofia
    Magalhaes, Joana
    Marinho, Carla
    Cotter, Jose
    DIGESTIVE DISEASES, 2021, 39 (06) : 653 - 662
  • [37] The Triglyceride-Glucose Index is Associated with Vitamin D Status in Metabolic-Associated Fatty Liver Disease
    Liu, Zhiping
    Zhang, Wensha
    Zhao, Zhiwei
    Li, Wenhao
    Zhang, Jinhua
    DIABETES METABOLIC SYNDROME AND OBESITY, 2023, 16 : 2651 - 2660
  • [38] Diagnostic ability using fatty liver and metabolic markers for metabolic-associated fatty liver disease stratified by metabolic/glycemic abnormalities
    Okada, Akira
    Yamada, Gen
    Kimura, Takeshi
    Hagiwara, Yasuhiro
    Yamaguchi, Satoko
    Kurakawa, Kayo Ikeda
    Nangaku, Masaomi
    Yamauchi, Toshimasa
    Matsuyama, Yutaka
    Kadowaki, Takashi
    JOURNAL OF DIABETES INVESTIGATION, 2023, 14 (03) : 463 - 478
  • [39] Metabolic-associated fatty liver disease: New nomenclature and approach with hot debate
    Fouad, Yasser
    WORLD JOURNAL OF HEPATOLOGY, 2023, 15 (02) : 123 - 128
  • [40] Increased risk of colorectal adenomas with metabolic-associated fatty liver disease components
    Ran, Dongsheng
    Xin, ChunLing
    Ma, Yingcai
    Lu, Yanyan
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2024, 48 (03)
12345